218 related articles for article (PubMed ID: 17298625)
1. Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme.
Ward N; Wright J; Marsh S; Norton J
Colorectal Dis; 2007 Mar; 9(3):258-61. PubMed ID: 17298625
[No Abstract] [Full Text] [Related]
2. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
Edwards JB
Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
[No Abstract] [Full Text] [Related]
3. [Colorectal cancer screening: immunological test for faecal occult blood preferred].
Jansen JB; van Rossum LG; Laheij RJ
Ned Tijdschr Geneeskd; 2009; 153():A474. PubMed ID: 19785842
[TBL] [Abstract][Full Text] [Related]
4. [Faecal occult blood test and mass screening for colorectal cancer].
Hiwatashi N; Shimada T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
[No Abstract] [Full Text] [Related]
5. Experiences of patients with false positive results from colorectal cancer screening.
Mant D; Fitzpatrick R; Hogg A; Fuller A; Farmer A; Verne J; Northover J
Br J Gen Pract; 1990 Oct; 40(339):423-5. PubMed ID: 2271264
[TBL] [Abstract][Full Text] [Related]
6. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
Nash GF
Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
[No Abstract] [Full Text] [Related]
7. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.
Saito H
J Med Screen; 2006; 13 Suppl 1():S6-7. PubMed ID: 17227634
[TBL] [Abstract][Full Text] [Related]
9. [Colorectal cancer screening is profitable].
Pikkarainen P
Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
[No Abstract] [Full Text] [Related]
10. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
Malila N; Hakama M; Pukkala E
Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
13. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
[TBL] [Abstract][Full Text] [Related]
14. Green-coloured results on guaiac-based faecal occult blood testing should be considered positive.
Skitek M
Ann Clin Biochem; 2005 May; 42(Pt 3):234-5; author reply 235. PubMed ID: 15949162
[No Abstract] [Full Text] [Related]
15. Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia?
Robinson MH; Thomas WM; Pye G; Hardcastle JD; Mangham CM
Eur J Surg Oncol; 1993 Dec; 19(6):539-42. PubMed ID: 8270040
[TBL] [Abstract][Full Text] [Related]
16. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer after positive screening faecal occult blood testing and negative assessment.
Zappa M; Visioli CB; Ciatto S; Grazzini G; Rubeca T; Bonanomi AG; Confortini M; Paci E; Castiglione G
Dig Liver Dis; 2007 Apr; 39(4):321-6. PubMed ID: 17314076
[TBL] [Abstract][Full Text] [Related]
19. Screening for colorectal cancer with Hemoccult-II in the average risk population.
Kronborg O
Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S44-8. PubMed ID: 9762237
[No Abstract] [Full Text] [Related]
20. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]